PureTech Health Stock (NASDAQ: PRTC) stock price, news, charts, stock research, profile.
Open | $27.330 |
Close | $27.480 |
Volume / Avg. | 327.000 / 3.333K |
Day Range | 27.330 - 27.480 |
52 Wk Range | 17.080 - 34.000 |
Market Cap | $741.822M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | - |
Days to Cover | 1.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PureTech Health (NASDAQ: PRTC) through any online brokerage.
Other companies in PureTech Health’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for PureTech Health (NASDAQ: PRTC) was reported by Piper Sandler on Thursday, August 25, 2022. The analyst firm set a price target for 44.00 expecting PRTC to rise to within 12 months (a possible 57.31% upside). 0 analyst firms have reported ratings in the last year.
The stock price for PureTech Health (NASDAQ: PRTC) is $27.97 last updated April 5, 2024 at 8:57 AM EDT.
There are no upcoming dividends for PureTech Health.
PureTech Health’s FY earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for PureTech Health.
PureTech Health is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.